4.3
Transdução de Sinal: Visão Geral
As células respondem a muitos tipos de informação, frequentemente por meio de proteínas receptoras posicionadas na membrana. Elas respondem a sinais q…
A transdução de sinal é um processo em que a ligação de um mensageiro extracelular inicia uma série de reações moleculares, levando a uma resposta celular.
Quando um ligante extracelular ou uma droga se liga a um receptor, ele altera a conformação dos receptores para ativá-lo. Esses receptores podem ser receptores acoplados à proteína G ou GPCRs, receptores ligados a enzimas, receptores nucleares ou canais iônicos dependentes de ligantes.
Os receptores ativados transmitem e amplificam o sinal de maneiras diferentes. Os canais iônicos facilitam o movimento iônico através da célula, alterando o potencial da membrana e mediando atividades celulares como neurotransmissão e contração muscular.
Os GPCRs se associam às proteínas G heterotriméricas para interagir com os efetores e produzir segundos mensageiros.
Em contraste, os receptores ligados a enzimas têm domínios de quinase intracelular que fosforilam vários efetores a jusante para modular a expressão gênica.
Alternativamente, drogas lipofílicas ou esteróides atravessam a bicamada para se ligar aos receptores nucleares citosólicos. Os complexos droga-receptor se translocam para o núcleo e regulam a transcrição gênica.
Q1: What happens when a ligand binds to a receptor during signal transduction?
When an extracellular ligand or drug binds a receptor, it changes the receptor's conformation to activate it. This activated receptor then transmits and amplifies the signal through different pathways depending on receptor type, initiating a cascade of molecular reactions that ultimately produces a cellular response.
Q2: How do G protein-coupled receptors transmit signals across the cell membrane?
GPCRs associate with heterotrimeric G proteins to interact with effectors and produce second messengers like cyclic AMP. These second messengers carry the signal to target proteins throughout the cell, allowing the transducer mechanism G protein-coupled receptors to amplify and relay the initial signal from the cell surface.
Q3: What role do ion channels play in signal transduction?
Ligand-gated ion channels facilitate ion movement across the cell membrane, changing the membrane potential and mediating cellular activities like neurotransmission and muscle contraction. Various drugs bind at the ligand binding site, allosteric site, or channel pore to regulate the opening and closing of the ligand-gated ion channel receptor gating mechanism.
Q4: How do enzyme-linked receptors differ from other receptor types?
Enzyme-linked receptors have intracellular kinase domains that phosphorylate multiple downstream effectors to modulate gene expression. Unlike GPCRs that use second messengers, these receptors directly activate a phosphorylation cascade, making them unique transmembrane proteins involved in cell proliferation, growth, differentiation, and immune responses.
Q5: How do nuclear receptors enable signal transduction for lipophilic drugs?
Lipophilic drugs and steroids cross the cell bilayer to bind cytosolic nuclear receptors. The drug-receptor complexes then translocate to the nucleus and regulate gene transcription, allowing these ligand-activated transcription factors to control genes involved in reproduction and metabolic pathways throughout the organism.
Q6: What are the three main steps involved in signal transduction?
Signal transduction involves reception, where a ligand binds a membrane receptor; transduction, where the receptor sends signals to intracellular messengers; and response, where those messengers convert the message into a cellular action. This three-step process allows cells to respond appropriately to chemical signals like hormones and neurotransmitters.
Q7: Why do pharmaceutical companies target specific receptor types when designing drugs?
Different receptor types activate distinct signaling pathways and produce different cellular responses. By targeting specific receptors involved in particular diseases, pharmaceutical companies can design drugs with different structural and chemical properties to modulate the appropriate signaling pathway, maximizing therapeutic benefit while minimizing unwanted effects.